Janux Therapeutics, Inc. - Common Stock – Jahresabschlüsse (NASDAQ:JANX) | MetaTrader

Vollständige Grafik anzeigen Full chart

Nachrichten

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Here's Why You Should Add JANX Stock to Your Portfolio Now

Insider-Verkauf bei Janux Therapeutics: Vizepräsidentin veräußert Aktienpaket

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

Undercovered Stocks: Western Digital, SAP, Toast And More

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value (JANX)

BofA senkt Kursziel für Janux Therapeutics nach Pipeline-Änderungen

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY)

Janux Therapeutics: H.C. Wainwright sieht erhebliches Kurspotenzial

Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?

Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings?